Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
4.170
+0.270 (6.92%)
Nov 5, 2024, 11:14 AM EST - Market open
Kodiak Sciences Employees
Kodiak Sciences had 111 employees as of December 31, 2023. The number of employees decreased by 1 or -0.89% compared to the previous year.
Employees
111
Change (1Y)
-1
Growth (1Y)
-0.89%
Revenue / Employee
n/a
Profits / Employee
-$1,780,892
Market Cap
218.87M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Adaptimmune Therapeutics | 449 |
Caribou Biosciences | 158 |
Nanobiotix | 102 |
MediWound | 100 |
Fulcrum Therapeutics | 76 |
Orchestra BioMed Holdings | 56 |
Cybin | 50 |
Corbus Pharmaceuticals Holdings | 19 |
KOD News
- 21 days ago - Kodiak Sciences to Present at Innovate Retina 2024 - PRNewsWire
- 6 weeks ago - Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time - PRNewsWire
- 6 weeks ago - Kodiak Sciences to Host Investor R&D Day on September 23, 2024 in New York City - PRNewsWire
- 2 months ago - Kodiak Sciences Announces Recent Business Highlights and Second Quarter 2024 Financial Results - PRNewsWire
- 5 months ago - Kodiak Sciences to Present at Upcoming Investor and Clinical Conferences - PRNewsWire
- 6 months ago - Kodiak Sciences Announces Recent Business Highlights and First Quarter 2024 Financial Results - PRNewsWire
- 6 months ago - Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer in Diabetic Retinopathy - PRNewsWire
- 6 months ago - Kodiak Sciences Data at ARVO 2024 Highlight Depth of Early and Late-Phase Retina Pipeline including Advancements with High Drug-Antibody-Ratio Therapeutics Built on Kodiak's Antibody Biopolymer Conjugate (ABC) Platform - PRNewsWire